The minimally
invasive cardiac surgery market is projected to grow at a
5-10% CAGR over the forecast period. Major factors driving growth
include increased prevalence of cardiovascular diseases (CVDs), rising demand
for minimally invasive cardiac procedures, growing aging population, patient
preference for minimally invasive procedures, technological advancement in
minimally invasive cardiac surgery, shift towards outpatient and ambulatory
surgery centers (ASCs), and rising awareness about cardiovascular health
conditions.
Minimally invasive cardiac surgery (MICS), sometimes
referred to as keyhole heart surgery, is a sophisticated technique used to
perform heart bypass procedures for treating coronary heart disease. In this
approach, the surgeon uses specialized surgical instruments to access the heart
through a small incision on the left side of the chest. Unlike traditional
open-heart surgery, which requires opening the chest cavity, MICS allows access
through the natural spaces between the ribs without the need for cutting. This
method is less invasive, resulting in reduced trauma and quicker patient
recovery.
Download a free sample report for in-depth market
insights
https://meditechinsights.com/minimally-invasive-cardiac-surgery-market/request-sample/
Growing demand for minimally invasive cardiac surgery
procedures fuels its demand
Minimally invasive cardiac procedures have revolutionized
heart surgery by offering safer and less invasive alternatives to traditional
open-heart techniques. The adoption of these methods is rapidly growing, driven
by the need to reduce patient trauma, shorten recovery times, and lower
healthcare costs. Procedures like cardiac catheterization and percutaneous
coronary intervention are increasingly preferred due to their significant
benefits over conventional approaches. These techniques utilize specialized
cardiology devices, such as catheters, stents, and guidewires, which are
witnessing rising demand. Moreover, minimally invasive approaches are widely
applied in various cardiac surgeries, including mitral valve repair, coronary
artery bypass grafting, and aortic valve replacement, further accelerating
market growth.
Shift towards minimally invasive cardiac surgery over
traditional heart surgery drives market growth
Minimally invasive cardiac surgery (MICS) has transformed
the treatment of various heart conditions, offering a safer and equally
effective alternative to traditional open-heart surgery. It provides several
significant advantages over conventional methods:
- Smaller
Incisions & Less Pain: With minimal incisions on the
breastbone, MICS reduces post-operative pain and scarring. This approach
also preserves chest function and improves breathing after surgery
- Faster
Recovery & Return to Daily Activities: Unlike traditional
heart surgeries, MICS allows patients to resume normal activities, such as
driving and working, much sooner often immediately after the initial
recovery phase
- Minimal
Blood Loss & Reduced Need for Transfusion: The use of robotic
instruments and small incisions minimizes blood loss during the procedure,
significantly lowering the need for transfusions and reducing the risk of
blood-borne infections
- Lower
Risk of Post-Surgical Infections: Due to the smaller incisions,
MICS greatly decreases the likelihood of infections, making it
particularly beneficial for diabetic and elderly patients with weaker
immune systems
- Minimal
Scarring & Faster Healing: With incisions as small as 2-4
inches, scarring is virtually non-existent, leading to quicker wound
healing with fewer complications
- Shorter
Hospital Stays: One of the greatest advantages of MICS is the
reduced recovery period. Patients typically stay in the hospital for about
five days, compared to nine days for those undergoing traditional
open-heart surgery, enabling a faster return to normal life with less
rehabilitative care.
By combining advanced surgical techniques with enhanced
patient outcomes, MICS continues to redefine the landscape of modern cardiac
surgery.
Competitive Landscape Analysis
The global minimally invasive cardiac surgery market is
marked by the presence of established and emerging market players such as Abbott
Laboratories; Intuitive Surgical; Stryker Corporation; GE HealthCare; Edwards
Lifesciences Corporation; Siemens Healthineers; Terumo Corporation; Johnson
& Johnson; Philips Healthcare; Medtronic; Boston Scientific Corporation;
Zimmer Biomet; Smith & Nephew; Olympus Corporation; and Micro
Interventional Devices (MID); among others. Some of the key strategies
adopted by market players include new product development, strategic
partnerships and collaborations, and investments.
Unlock key
data with a sample report for competitive analysis:
https://meditechinsights.com/minimally-invasive-cardiac-surgery-market/request-sample/
Market Segmentation
This report by Medi-Tech Insights provides the size of
the global minimally invasive cardiac surgery market at the regional- and
country-level from 2023 to 2030. The report further segments the market based
on surgery type, procedure type, and end user.
- Market
Size & Forecast (2023-2030), By Surgery Type, USD Million
- Robotic-assisted
Surgery
- Thoracoscopy
Surgery
- Market
Size & Forecast (2023-2030), By Procedure Type, USD Million
- Aortic
Valve Repair/Replacement
- Mitral
Valve Repair/Replacement
- Surgical
Radiofrequency Ablation for Atrial Fibrillation
- Tricuspid
Valve Repair or Replacement
- Atrial
Septal Defect (ASD)
- Ventricular
Assist Device (VAD) Implantation
- Coronary
Artery Bypass Grafting (CABG)
- Other
Procedures
- Market
Size & Forecast (2023-2030), By End User, USD Million
- Hospitals
- Ambulatory
Surgical Centers (ASCs)
- Speciality
Clinics
- Others
- Market
Size & Forecast (2023-2030), By Region, USD Million
- North
America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest
of Europe
- Asia
Pacific
- China
- India
- Japan
- Rest
of Asia Pacific
- Latin
America
- Middle
East & Africa
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research
& insights firm. Our clients include Fortune 500 companies, blue-chip
investors & hyper-growth start-ups. We have completed 100+ projects in
Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma
Services in the areas of market assessments, due diligence, competitive
intelligence, market sizing and forecasting, pricing analysis &
go-to-market strategy. Our methodology includes rigorous secondary research
combined with deep-dive interviews with industry-leading CXO, VPs, and key
demand/supply side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
Comments
Post a Comment